AbCellera Biologics Statistics
Total Valuation
ABCL has a market cap or net worth of $1.37 billion. The enterprise value is $957.66 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ABCL has 298.83 million shares outstanding. The number of shares has increased by 1.69% in one year.
Current Share Class | 298.83M |
Shares Outstanding | 298.83M |
Shares Change (YoY) | +1.69% |
Shares Change (QoQ) | +0.27% |
Owned by Insiders (%) | 22.94% |
Owned by Institutions (%) | 35.15% |
Float | 202.75M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 41.33 |
Forward PS | 76.07 |
PB Ratio | 1.35 |
P/TBV Ratio | 1.49 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 29.13 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.07, with a Debt / Equity ratio of 0.14.
Current Ratio | 11.07 |
Quick Ratio | 9.50 |
Debt / Equity | 0.14 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -15.64% and return on invested capital (ROIC) is -13.22%.
Return on Equity (ROE) | -15.64% |
Return on Assets (ROA) | -10.95% |
Return on Invested Capital (ROIC) | -13.22% |
Return on Capital Employed (ROCE) | -18.48% |
Revenue Per Employee | $55,161 |
Profits Per Employee | -$277,961 |
Employee Count | 596 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | -33.12M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +73.81% in the last 52 weeks. The beta is 0.65, so ABCL's price volatility has been lower than the market average.
Beta (5Y) | 0.65 |
52-Week Price Change | +73.81% |
50-Day Moving Average | 3.88 |
200-Day Moving Average | 2.98 |
Relative Strength Index (RSI) | 56.44 |
Average Volume (20 Days) | 6,776,721 |
Short Selling Information
The latest short interest is 39.81 million, so 13.32% of the outstanding shares have been sold short.
Short Interest | 39.81M |
Short Previous Month | 35.72M |
Short % of Shares Out | 13.32% |
Short % of Float | 19.63% |
Short Ratio (days to cover) | 5.88 |
Income Statement
In the last 12 months, ABCL had revenue of $32.88 million and -$165.67 million in losses. Loss per share was -$0.56.
Revenue | 32.88M |
Gross Profit | -135.88M |
Operating Income | -246.66M |
Pretax Income | -178.81M |
Net Income | -165.67M |
EBITDA | -218.38M |
EBIT | -246.66M |
Loss Per Share | -$0.56 |
Full Income Statement Balance Sheet
The company has $553.08 million in cash and $142.08 million in debt, giving a net cash position of $411.00 million or $1.38 per share.
Cash & Cash Equivalents | 553.08M |
Total Debt | 142.08M |
Net Cash | 411.00M |
Net Cash Per Share | $1.38 |
Equity (Book Value) | 1.01B |
Book Value Per Share | 3.41 |
Working Capital | 675.12M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$80.84 million and capital expenditures -$58.15 million, giving a free cash flow of -$138.99 million.
Operating Cash Flow | -80.84M |
Capital Expenditures | -58.15M |
Free Cash Flow | -138.99M |
FCF Per Share | -$0.47 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -750.29% |
Pretax Margin | -604.66% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ABCL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.69% |
Shareholder Yield | -1.69% |
Earnings Yield | -12.10% |
FCF Yield | -10.16% |
Analyst Forecast
The average price target for ABCL is $8.00, which is 74.67% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.00 |
Price Target Difference | 74.67% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | 48.44% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ABCL has an Altman Z-Score of 1.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.28 |
Piotroski F-Score | 3 |